Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2003
10/23/2003US20030198944 Compositions and methods for reverse transcription of nucleic acid molecules
10/23/2003US20030198939 In vitro culturing of monocytes in presence of monoclonal antibody
10/23/2003US20030198681 Method of making a protein polymer and uses of the polymer
10/23/2003US20030198646 Sealed tube containing papilla cells; induction hair growth
10/23/2003US20030198628 Harvesting pancrea tissue; grafting into body cavity; increase insulin concentration
10/23/2003US20030198627 siRNA knockout assay method and constructs
10/23/2003US20030198622 vaccine including a polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy
10/23/2003US20030198621 Polynucleotides encoding antigenic HIV type B and/or type C polypeptides, polypeptides and uses thereof
10/23/2003US20030198618 T1 receptor-like ligand II and uses thereof
10/23/2003DE19932720C2 Verfahren zur Messung der Wirkung von Stoffen auf die Erregbarkeit zentralnervöser Zellen oder Zellverbände Method for measuring the effects of substances on the excitability of central nervous cells or cell clusters
10/23/2003CA2853267A1 Automated tissue engineering system comprising sensors linked to a microprocessor
10/23/2003CA2521946A1 Method of identifying transmembrane protein-interacting compounds
10/23/2003CA2503681A1 Method for isolating and measuring proliferation of long-term label retaining cells and stem cells
10/23/2003CA2485350A1 Automated tissue engineering system comprising sensors linked to a microprocessor
10/23/2003CA2483451A1 Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance
10/23/2003CA2482893A1 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells
10/23/2003CA2482841A1 Method of measuring human cyp3a inducibility
10/23/2003CA2482718A1 Derivatives of the il-2 receptor gamma chain, their production and use
10/23/2003CA2482716A1 Method of forming pancreatic .beta. cells from mesenchymal cells
10/23/2003CA2482713A1 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells
10/23/2003CA2482395A1 Antiviral therapy on the basis of rna interference
10/23/2003CA2482387A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003CA2482351A1 Vascularized human skin equivalent
10/23/2003CA2481922A1 Antibodies that bind to integrin alpha-v-beta-6 and methods of use thereof
10/23/2003CA2481509A1 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003CA2481508A1 G-protein coupled receptor ligands and methods
10/23/2003CA2481503A1 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
10/23/2003CA2481478A1 Stimulation of nerve cell regeneration
10/23/2003CA2481386A1 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
10/23/2003CA2481385A1 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
10/23/2003CA2481328A1 Monomeric and dimeric fluorescent protein variants and methods for making same
10/23/2003CA2481256A1 Embryo modification and implantation
10/23/2003CA2481087A1 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
10/23/2003CA2474486A1 Targeted chromosomal mutagenesis using zinc finger nucleases
10/22/2003EP1355156A2 A human endothelin receptor
10/22/2003EP1354957A1 Process for producing coenzyme q 10
10/22/2003EP1354949A1 Human fgf23 protein mutant lowering blood phosphorus level
10/22/2003EP1354943A2 Monoclonal antibodies, hybridomas, cell isolation method, isolated cells and immunological diagnostic method
10/22/2003EP1354942A1 Induction of insulin-producing cells
10/22/2003EP1354891A1 Medicament comprising NK4 gene or recombinant NK4 protein
10/22/2003EP1354598A2 Therapeutic uses of BR43X2 soluble receptors
10/22/2003EP1354509A1 A canola variety producing a seed with reduced glucosinolates and linolenic acid yielding an oil with low sulfur, improved sensory characteristics and increased oxidative stability
10/22/2003EP1354204A2 Hcv antigen/antibody combination assay
10/22/2003EP1354055A1 Neocentromere-based mini-chromosomes or artificial chromosomes
10/22/2003EP1354048A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/22/2003EP1354047A2 Methods for screening compounds that modulate lipid metabolism
10/22/2003EP1354046A2 A member of the lysyl oxidase gene family
10/22/2003EP1354043A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
10/22/2003EP1354042A2 Proteins and nucleic acids encoding same
10/22/2003EP1354040A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/22/2003EP1354039A2 Atp-binding cassette transporter-like molecules and uses thereof
10/22/2003EP1354038A2 Double-stranded rna-mediated gene suppression
10/22/2003EP1354034A2 Transgenic transchromosomal rodents for making human antibodies
10/22/2003EP1354029A2 Foggy
10/22/2003EP1353956A1 Method for surface display of proteins on genetic carriers
10/22/2003EP1353955A2 High affinity antibodies
10/22/2003EP1353954A2 Anticoagulants and their uses
10/22/2003EP1353953A2 Mu-1, member of the cytokine receptor family
10/22/2003EP1353952A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
10/22/2003EP1353949A2 Compositions and methods relating to ovary specific genes and proteins
10/22/2003EP1353946A2 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein
10/22/2003EP1353945A2 Polymorphic kinase anchor proteins and nucleic acids encoding the same
10/22/2003EP1353706A1 Method for sterilizing bioactive materials
10/22/2003EP1353702A2 Genetic engineering of vascular grafts to resist disease
10/22/2003EP1353686A2 Mhc class i associated peptides for prevention and treatment of tuberculosis
10/22/2003EP1003860B1 Modified dorsal tissue affecting factor and compositions
10/22/2003EP0927270B1 Lyophilization of cultured human cells to preserve rna and dna
10/22/2003EP0922059B1 Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
10/22/2003EP0851927B1 Compounds for immunotherapy and diagnosis of tuberculosis
10/22/2003EP0815221B1 A novel growth factor and a genetic sequence encoding same
10/22/2003EP0801677B1 Production of a contractile smooth muscle
10/22/2003EP0659217B1 CLONING AND EXPRESSION OF beta APP-C100 RECEPTOR
10/22/2003EP0658209B1 Endothelial lineage specific transcriptional regulatory element from tek
10/22/2003CN1451048A Expression of biologically active polypeptides in duckweed
10/22/2003CN1451043A Dual specificity antibodies and methods of making and using
10/22/2003CN1451042A Method of monitoring HIV drug resistance
10/22/2003CN1451040A Method for preparing human thrombopoietin polytides by mammalian cell cultures
10/22/2003CN1451038A Attenuated influenza virus useful as vaccine
10/22/2003CN1451016A Human cervical cancer suppressor protein, polynucleotide encoding the protein cell transformed with the polynucleotide and method
10/22/2003CN1450909A Monoclonal antibodies and antibody cocktail for detection of prion protein as an indiction of transmissible spongiform encephalopathies
10/22/2003CN1450907A Beta glycan as an inhibin receptor and uses thereof
10/22/2003CN1450857A Cryopreservation of sperm
10/22/2003CN1450057A Diazosulfide compound and application in plant cell thereof
10/22/2003CN1125179C Breeding disease-resistance crop with two-kind anti-fungus gen coexpressed in cell or external cell
10/22/2003CN1125178C Coding sequence of human serine/threonine kinase Ôàí its encoded polypeptide and preparing process
10/22/2003CN1125177C Coding Sequence of human short-chain alcohol dehydrogenase its encoded polypeptide and its preparing process
10/22/2003CN1125174C Recombinant phages
10/22/2003CN1125083C Monoclonal antibody active against CD44V6
10/22/2003CN1125082C Human chemokine beta-8 chemokine beta-1 and macrophage inflammatory protein-4
10/21/2003US6635806 Methods and compositions for expression of transgenes in plants
10/21/2003US6635805 Recombinant DNA construct which can be transcribed in plant cell to RNA transcript comprising plant virus sequence from RNA virus which can replicate in cytoplasm of cell, comprising foreign targeting sequence which silences target gene
10/21/2003US6635804 Nucleotide sequences coding enzymatic protein for use in generating plants with amplified starch biosynthesis
10/21/2003US6635802 Culturing mammalian cell population in serum starvation media containing apoptosis inhibitor to increase number of cells at G0/G1 stage of cell cycle within cell population, increasing number of nuclear transfer competent cells
10/21/2003US6635752 Diagnosis of Aids
10/21/2003US6635745 Rapamycin assay
10/21/2003US6635744 Substantially pure fibroblast growth factor homologous factor-4 polypeptide having specified amino acid sequence; diagnosis and treatment of neurodegenerative and neoplastic disorders
10/21/2003US6635496 Plate-through hard mask for MRAM devices
10/21/2003US6635479 Hypothalamus-specific polypeptides
10/21/2003US6635478 Transfecting mammalian cell with a construct for stable expression of a gene product and a second construct comprising a antibiotic resistance gene; use in drug discovery
10/21/2003US6635472 Polynucleotide constructs which can replicate episomally in vertebrate cells without integration into the chromosomal DNA of the host; reverse transcription; use in gene transfer, gene therapy and vaccines